RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 25,717 Value ($000) $0 Avg Close $4.95 Range $3.81 - $7.18

Q1 2025

Shares 30,153 Value ($000) $0 Avg Close $7.29 Range $5.19 - $12.36

Q4 2023

Shares 10,860 Value ($000) $0 Avg Close $7.13 Range $4.97 - $11.17

Q4 2022

Shares 22,603 Value ($000) $0 Avg Close $9.81 Range $7.04 - $13.29

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	25,717	$0	$4.95	$3.81 - $7.18
Q1 2025	30,153	$0	$7.29	$5.19 - $12.36
Q4 2023	10,860	$0	$7.13	$4.97 - $11.17
Q4 2022	22,603	$0	$9.81	$7.04 - $13.29